Patent ID: 11959143
Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 8:
9. A kit for distinguishing melanoma cells from normal and dysplastic nevi cells in a skin lesion sample from a subject, comprising one or more primer pairs that can be used for amplifying miRNA in the skin lesion sample, wherein the miRNAs comprise miR-339-5p, miR-15b, miR-572, miR-425, miR-1202, HBII-382_s, miR-1225-5p, miR-30c, miR-106b-star, miR-125a-5p, mgU6-53B, miR-25, miR-939, miR-92b-star, miR-500-star, miR-22, HBII-142_x, miR-181b, HBII-142, miR-663, miR-1224-5p, HBII-85-6-x, miR-1301, miR-345, miR-30a-star, ENSG00000202327, miR-92a, miR-127-3p, HBII-85-26, miR-31, miR-921, miR-146b-5p, miR-768-3p, miR-708, miR-139-5p, ACA24_x, miR-501-3p, or miR-502-3p; and wherein at least one primer pair is detectably labeled.